Furthermore, it has been shown in our lab that triggering of TLR9 signaling in a Burkitt's lymphoma derived cell line blocks reactivation of EBV lytic cycle, reinforcing the risk of cell transformation [40]. This evidence concerns the gene TLR9 and Burkitt lymphoma.